Lorajmine (17-monochloroacetylajmaline) is a drug that is a potent sodium channel blocker (more specifically, a class Ia antiarrhythmic agent) that was used for treating arrhythmia.[1][2][3] It is derived from ajmaline, an alkaloid from the roots of Rauvolfia serpentina, by synthetically adding a chloroacetate residue.
Clinical data | |
---|---|
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
ChEMBL |
|
ECHA InfoCard | 100.051.185 |
Chemical and physical data | |
Formula | C22H27ClN2O3 |
Molar mass | 402.92 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(verify) |